Siren »

Oculis Holding shares owned by Siren

Quarter-by-quarter ownership of Oculis Holding (OCS) shares owned by Siren from 13F filings

Historical chart of Siren investment in Oculis Holding

Tip: Access up to 7 years of quarterly data

All positions including Oculis Holding held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oculis Holding by Siren

Quarter filed Position value Share count Share price at filing
2026-06-30 $8.7M 625k 13.87

More positions owned by Siren

Scholar Rock Hldg Corp (SRRK)
Kymera Therapeutics (KYMR)
Erasca (ERAS)
Veradermics Common Stock (MANE)
Tango Therapeutics (TNGX)
Revolution Medicines (RVMD)
Bicara Therapeutics (BCAX)
Arrowhead Pharmaceuticals (ARWR)
BeOne Medicines Sponsored Ads (ONC)
Edgewise Therapeutics (EWTX)
Rhythm Pharmaceuticals (RYTM)
Lexicon Pharmaceuticals Com New (LXRX)
Enliven Therapeutics (ELVN)
Spyre Therapeutics Com New (SYRE)
Parabilis Medicines

View all positions for Siren

Top funds holding Oculis Holding

EQT Fund Management S.a r.l.
Gildi - lifeyrissjodur
Standard Life Aberdeen
Millennium Management
Pivotal bioVenture Partners Investment Advisor
Citadel Advisors
Braidwell
Perceptive Advisors
Saturn V Capital Management
Sr One Capital Management
Siren
Ameriprise Financial
Wellington Management Company
Partner Fund Management
Franklin Resources

View all funds holding Oculis Holding